Medical Cannabis and Cannabinoids · Published 2024-04-16 · DOI 10.1159/000538694
INTRODUCTION: Subjective improvement in gastrointestinal (GI) symptoms was assessed among patients using medical marijuana (MMJ). METHODS: Participants completed surveys at 0 days, 30 days, 6 months, and 12 months with questions about the severity of their GI symptoms on a scale from 1 (mild) to 3 (severe). RESULTS: In each survey, participants reported a significant decrease in gastrointestinal symptom severity when using MMJ versus when not using MMJ (p < 0.05). The most common self-reported side effects from using MMJ were increased appetite (12%–21.4%), fatigue (6%–16.7%), anxiety (4%–11.9%), cough (4%–11.9%), headache (6%–7.9%), and dry mouth (4%–7.1%). CONCLUSION: In patients with chronic GI symptoms, MMJ may provide persistent symptom severity improvement. Limited product availability and mild to moderate side effects are factors to consider before trialing MMJ.
Abstract from DOAJ. Public domain (CC0 1.0).
Read the article at the publisher →